Global Ipilimumab Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Ipilimumab Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Ipilimumab by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Ipilimumab by Country/Region, 2017, 2022 & 2028

2.2 Ipilimumab Segment by Type

2.2.1 PD - L1 Antagonists

2.2.2 CTLA4 Antagonists

2.2.3 Immunocheckpoint Inhibitors

2.2.4 Other

2.3 Ipilimumab Sales by Type

2.3.1 Global Ipilimumab Sales Market Share by Type (2017-2022)

2.3.2 Global Ipilimumab Revenue and Market Share by Type (2017-2022)

2.3.3 Global Ipilimumab Sale Price by Type (2017-2022)

2.4 Ipilimumab Segment by Application

2.4.1 Cancer

2.4.2 Melanoma

2.5 Ipilimumab Sales by Application

2.5.1 Global Ipilimumab Sale Market Share by Application (2017-2022)

2.5.2 Global Ipilimumab Revenue and Market Share by Application (2017-2022)

2.5.3 Global Ipilimumab Sale Price by Application (2017-2022)

3 Global Ipilimumab by Company

3.1 Global Ipilimumab Breakdown Data by Company

3.1.1 Global Ipilimumab Annual Sales by Company (2020-2022)

3.1.2 Global Ipilimumab Sales Market Share by Company (2020-2022)

3.2 Global Ipilimumab Annual Revenue by Company (2020-2022)

3.2.1 Global Ipilimumab Revenue by Company (2020-2022)

3.2.2 Global Ipilimumab Revenue Market Share by Company (2020-2022)

3.3 Global Ipilimumab Sale Price by Company

3.4 Key Manufacturers Ipilimumab Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Ipilimumab Product Location Distribution

3.4.2 Players Ipilimumab Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Ipilimumab by Geographic Region

4.1 World Historic Ipilimumab Market Size by Geographic Region (2017-2022)

4.1.1 Global Ipilimumab Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Ipilimumab Annual Revenue by Geographic Region

4.2 World Historic Ipilimumab Market Size by Country/Region (2017-2022)

4.2.1 Global Ipilimumab Annual Sales by Country/Region (2017-2022)

4.2.2 Global Ipilimumab Annual Revenue by Country/Region

4.3 Americas Ipilimumab Sales Growth

4.4 APAC Ipilimumab Sales Growth

4.5 Europe Ipilimumab Sales Growth

4.6 Middle East & Africa Ipilimumab Sales Growth

5 Americas

5.1 Americas Ipilimumab Sales by Country

5.1.1 Americas Ipilimumab Sales by Country (2017-2022)

5.1.2 Americas Ipilimumab Revenue by Country (2017-2022)

5.2 Americas Ipilimumab Sales by Type

5.3 Americas Ipilimumab Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Ipilimumab Sales by Region

6.1.1 APAC Ipilimumab Sales by Region (2017-2022)

6.1.2 APAC Ipilimumab Revenue by Region (2017-2022)

6.2 APAC Ipilimumab Sales by Type

6.3 APAC Ipilimumab Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Ipilimumab by Country

7.1.1 Europe Ipilimumab Sales by Country (2017-2022)

7.1.2 Europe Ipilimumab Revenue by Country (2017-2022)

7.2 Europe Ipilimumab Sales by Type

7.3 Europe Ipilimumab Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Ipilimumab by Country

8.1.1 Middle East & Africa Ipilimumab Sales by Country (2017-2022)

8.1.2 Middle East & Africa Ipilimumab Revenue by Country (2017-2022)

8.2 Middle East & Africa Ipilimumab Sales by Type

8.3 Middle East & Africa Ipilimumab Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Ipilimumab

10.3 Manufacturing Process Analysis of Ipilimumab

10.4 Industry Chain Structure of Ipilimumab

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Ipilimumab Distributors

11.3 Ipilimumab Customer

12 World Forecast Review for Ipilimumab by Geographic Region

12.1 Global Ipilimumab Market Size Forecast by Region

12.1.1 Global Ipilimumab Forecast by Region (2023-2028)

12.1.2 Global Ipilimumab Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Ipilimumab Forecast by Type

12.7 Global Ipilimumab Forecast by Application

13 Key Players Analysis

13.1 Gilead

13.1.1 Gilead Company Information

13.1.2 Gilead Ipilimumab Product Offered

13.1.3 Gilead Ipilimumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Gilead Main Business Overview

13.1.5 Gilead Latest Developments

13.2 BMS

13.2.1 BMS Company Information

13.2.2 BMS Ipilimumab Product Offered

13.2.3 BMS Ipilimumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 BMS Main Business Overview

13.2.5 BMS Latest Developments

13.3 Ono

13.3.1 Ono Company Information

13.3.2 Ono Ipilimumab Product Offered

13.3.3 Ono Ipilimumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Ono Main Business Overview

13.3.5 Ono Latest Developments

13.4 Roche

13.4.1 Roche Company Information

13.4.2 Roche Ipilimumab Product Offered

13.4.3 Roche Ipilimumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Roche Main Business Overview

13.4.5 Roche Latest Developments

13.5 Prestige BioPharma

13.5.1 Prestige BioPharma Company Information

13.5.2 Prestige BioPharma Ipilimumab Product Offered

13.5.3 Prestige BioPharma Ipilimumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Prestige BioPharma Main Business Overview

13.5.5 Prestige BioPharma Latest Developments

13.6 Avacta

13.6.1 Avacta Company Information

13.6.2 Avacta Ipilimumab Product Offered

13.6.3 Avacta Ipilimumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Avacta Main Business Overview

13.6.5 Avacta Latest Developments

13.7 Baxter

13.7.1 Baxter Company Information

13.7.2 Baxter Ipilimumab Product Offered

13.7.3 Baxter Ipilimumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Baxter Main Business Overview

13.7.5 Baxter Latest Developments

13.8 Shenyang Sansheng Pharmaceutical

13.8.1 Shenyang Sansheng Pharmaceutical Company Information

13.8.2 Shenyang Sansheng Pharmaceutical Ipilimumab Product Offered

13.8.3 Shenyang Sansheng Pharmaceutical Ipilimumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Shenyang Sansheng Pharmaceutical Main Business Overview

13.8.5 Shenyang Sansheng Pharmaceutical Latest Developments

14 Research Findings and Conclusion

Table 1. Ipilimumab Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Ipilimumab Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of PD - L1 Antagonists

Table 4. Major Players of CTLA4 Antagonists

Table 5. Major Players of Immunocheckpoint Inhibitors

Table 6. Major Players of Other

Table 7. Global Ipilimumab Sales by Type (2017-2022) & (KG)

Table 8. Global Ipilimumab Sales Market Share by Type (2017-2022)

Table 9. Global Ipilimumab Revenue by Type (2017-2022) & ($ million)

Table 10. Global Ipilimumab Revenue Market Share by Type (2017-2022)

Table 11. Global Ipilimumab Sale Price by Type (2017-2022) & (US$/G)

Table 12. Global Ipilimumab Sales by Application (2017-2022) & (KG)

Table 13. Global Ipilimumab Sales Market Share by Application (2017-2022)

Table 14. Global Ipilimumab Revenue by Application (2017-2022)

Table 15. Global Ipilimumab Revenue Market Share by Application (2017-2022)

Table 16. Global Ipilimumab Sale Price by Application (2017-2022) & (US$/G)

Table 17. Global Ipilimumab Sales by Company (2020-2022) & (KG)

Table 18. Global Ipilimumab Sales Market Share by Company (2020-2022)

Table 19. Global Ipilimumab Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Ipilimumab Revenue Market Share by Company (2020-2022)

Table 21. Global Ipilimumab Sale Price by Company (2020-2022) & (US$/G)

Table 22. Key Manufacturers Ipilimumab Producing Area Distribution and Sales Area

Table 23. Players Ipilimumab Products Offered

Table 24. Ipilimumab Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Ipilimumab Sales by Geographic Region (2017-2022) & (KG)

Table 28. Global Ipilimumab Sales Market Share Geographic Region (2017-2022)

Table 29. Global Ipilimumab Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Ipilimumab Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Ipilimumab Sales by Country/Region (2017-2022) & (KG)

Table 32. Global Ipilimumab Sales Market Share by Country/Region (2017-2022)

Table 33. Global Ipilimumab Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Ipilimumab Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Ipilimumab Sales by Country (2017-2022) & (KG)

Table 36. Americas Ipilimumab Sales Market Share by Country (2017-2022)

Table 37. Americas Ipilimumab Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Ipilimumab Revenue Market Share by Country (2017-2022)

Table 39. Americas Ipilimumab Sales by Type (2017-2022) & (KG)

Table 40. Americas Ipilimumab Sales Market Share by Type (2017-2022)

Table 41. Americas Ipilimumab Sales by Application (2017-2022) & (KG)

Table 42. Americas Ipilimumab Sales Market Share by Application (2017-2022)

Table 43. APAC Ipilimumab Sales by Region (2017-2022) & (KG)

Table 44. APAC Ipilimumab Sales Market Share by Region (2017-2022)

Table 45. APAC Ipilimumab Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Ipilimumab Revenue Market Share by Region (2017-2022)

Table 47. APAC Ipilimumab Sales by Type (2017-2022) & (KG)

Table 48. APAC Ipilimumab Sales Market Share by Type (2017-2022)

Table 49. APAC Ipilimumab Sales by Application (2017-2022) & (KG)

Table 50. APAC Ipilimumab Sales Market Share by Application (2017-2022)

Table 51. Europe Ipilimumab Sales by Country (2017-2022) & (KG)

Table 52. Europe Ipilimumab Sales Market Share by Country (2017-2022)

Table 53. Europe Ipilimumab Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Ipilimumab Revenue Market Share by Country (2017-2022)

Table 55. Europe Ipilimumab Sales by Type (2017-2022) & (KG)

Table 56. Europe Ipilimumab Sales Market Share by Type (2017-2022)

Table 57. Europe Ipilimumab Sales by Application (2017-2022) & (KG)

Table 58. Europe Ipilimumab Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Ipilimumab Sales by Country (2017-2022) & (KG)

Table 60. Middle East & Africa Ipilimumab Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Ipilimumab Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Ipilimumab Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Ipilimumab Sales by Type (2017-2022) & (KG)

Table 64. Middle East & Africa Ipilimumab Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Ipilimumab Sales by Application (2017-2022) & (KG)

Table 66. Middle East & Africa Ipilimumab Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Ipilimumab

Table 68. Key Market Challenges & Risks of Ipilimumab

Table 69. Key Industry Trends of Ipilimumab

Table 70. Ipilimumab Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Ipilimumab Distributors List

Table 73. Ipilimumab Customer List

Table 74. Global Ipilimumab Sales Forecast by Region (2023-2028) & (KG)

Table 75. Global Ipilimumab Sales Market Forecast by Region

Table 76. Global Ipilimumab Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Ipilimumab Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Ipilimumab Sales Forecast by Country (2023-2028) & (KG)

Table 79. Americas Ipilimumab Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Ipilimumab Sales Forecast by Region (2023-2028) & (KG)

Table 81. APAC Ipilimumab Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Ipilimumab Sales Forecast by Country (2023-2028) & (KG)

Table 83. Europe Ipilimumab Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Ipilimumab Sales Forecast by Country (2023-2028) & (KG)

Table 85. Middle East & Africa Ipilimumab Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Ipilimumab Sales Forecast by Type (2023-2028) & (KG)

Table 87. Global Ipilimumab Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Ipilimumab Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Ipilimumab Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Ipilimumab Sales Forecast by Application (2023-2028) & (KG)

Table 91. Global Ipilimumab Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Ipilimumab Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Ipilimumab Revenue Market Share Forecast by Application (2023-2028)

Table 94. Gilead Basic Information, Ipilimumab Manufacturing Base, Sales Area and Its Competitors

Table 95. Gilead Ipilimumab Product Offered

Table 96. Gilead Ipilimumab Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 97. Gilead Main Business

Table 98. Gilead Latest Developments

Table 99. BMS Basic Information, Ipilimumab Manufacturing Base, Sales Area and Its Competitors

Table 100. BMS Ipilimumab Product Offered

Table 101. BMS Ipilimumab Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 102. BMS Main Business

Table 103. BMS Latest Developments

Table 104. Ono Basic Information, Ipilimumab Manufacturing Base, Sales Area and Its Competitors

Table 105. Ono Ipilimumab Product Offered

Table 106. Ono Ipilimumab Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 107. Ono Main Business

Table 108. Ono Latest Developments

Table 109. Roche Basic Information, Ipilimumab Manufacturing Base, Sales Area and Its Competitors

Table 110. Roche Ipilimumab Product Offered

Table 111. Roche Ipilimumab Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 112. Roche Main Business

Table 113. Roche Latest Developments

Table 114. Prestige BioPharma Basic Information, Ipilimumab Manufacturing Base, Sales Area and Its Competitors

Table 115. Prestige BioPharma Ipilimumab Product Offered

Table 116. Prestige BioPharma Ipilimumab Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 117. Prestige BioPharma Main Business

Table 118. Prestige BioPharma Latest Developments

Table 119. Avacta Basic Information, Ipilimumab Manufacturing Base, Sales Area and Its Competitors

Table 120. Avacta Ipilimumab Product Offered

Table 121. Avacta Ipilimumab Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 122. Avacta Main Business

Table 123. Avacta Latest Developments

Table 124. Baxter Basic Information, Ipilimumab Manufacturing Base, Sales Area and Its Competitors

Table 125. Baxter Ipilimumab Product Offered

Table 126. Baxter Ipilimumab Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 127. Baxter Main Business

Table 128. Baxter Latest Developments

Table 129. Shenyang Sansheng Pharmaceutical Basic Information, Ipilimumab Manufacturing Base, Sales Area and Its Competitors

Table 130. Shenyang Sansheng Pharmaceutical Ipilimumab Product Offered

Table 131. Shenyang Sansheng Pharmaceutical Ipilimumab Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 132. Shenyang Sansheng Pharmaceutical Main Business

Table 133. Shenyang Sansheng Pharmaceutical Latest Developments

List of Figures

Figure 1. Picture of Ipilimumab

Figure 2. Ipilimumab Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Ipilimumab Sales Growth Rate 2017-2028 (KG)

Figure 7. Global Ipilimumab Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Ipilimumab Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of PD - L1 Antagonists

Figure 10. Product Picture of CTLA4 Antagonists

Figure 11. Product Picture of Immunocheckpoint Inhibitors

Figure 12. Product Picture of Other

Figure 13. Global Ipilimumab Sales Market Share by Type in 2021

Figure 14. Global Ipilimumab Revenue Market Share by Type (2017-2022)

Figure 15. Ipilimumab Consumed in Cancer

Figure 16. Global Ipilimumab Market: Cancer (2017-2022) & (KG)

Figure 17. Ipilimumab Consumed in Melanoma

Figure 18. Global Ipilimumab Market: Melanoma (2017-2022) & (KG)

Figure 19. Global Ipilimumab Sales Market Share by Application (2017-2022)

Figure 20. Global Ipilimumab Revenue Market Share by Application in 2021

Figure 21. Ipilimumab Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Ipilimumab Revenue Market Share by Company in 2021

Figure 23. Global Ipilimumab Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Ipilimumab Revenue Market Share by Geographic Region in 2021

Figure 25. Global Ipilimumab Sales Market Share by Region (2017-2022)

Figure 26. Global Ipilimumab Revenue Market Share by Country/Region in 2021

Figure 27. Americas Ipilimumab Sales 2017-2022 (KG)

Figure 28. Americas Ipilimumab Revenue 2017-2022 ($ Millions)

Figure 29. APAC Ipilimumab Sales 2017-2022 (KG)

Figure 30. APAC Ipilimumab Revenue 2017-2022 ($ Millions)

Figure 31. Europe Ipilimumab Sales 2017-2022 (KG)

Figure 32. Europe Ipilimumab Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Ipilimumab Sales 2017-2022 (KG)

Figure 34. Middle East & Africa Ipilimumab Revenue 2017-2022 ($ Millions)

Figure 35. Americas Ipilimumab Sales Market Share by Country in 2021

Figure 36. Americas Ipilimumab Revenue Market Share by Country in 2021

Figure 37. United States Ipilimumab Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Ipilimumab Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Ipilimumab Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Ipilimumab Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Ipilimumab Sales Market Share by Region in 2021

Figure 42. APAC Ipilimumab Revenue Market Share by Regions in 2021

Figure 43. China Ipilimumab Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Ipilimumab Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Ipilimumab Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Ipilimumab Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Ipilimumab Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Ipilimumab Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Ipilimumab Sales Market Share by Country in 2021

Figure 50. Europe Ipilimumab Revenue Market Share by Country in 2021

Figure 51. Germany Ipilimumab Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Ipilimumab Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Ipilimumab Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Ipilimumab Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Ipilimumab Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Ipilimumab Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Ipilimumab Revenue Market Share by Country in 2021

Figure 58. Egypt Ipilimumab Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Ipilimumab Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Ipilimumab Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Ipilimumab Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Ipilimumab Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Ipilimumab in 2021

Figure 64. Manufacturing Process Analysis of Ipilimumab

Figure 65. Industry Chain Structure of Ipilimumab

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles